BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25189618)

  • 1. CRL4B interacts with and coordinates the SIN3A-HDAC complex to repress CDKN1A and drive cell cycle progression.
    Ji Q; Hu H; Yang F; Yuan J; Yang Y; Jiang L; Qian Y; Jiang B; Zou Y; Wang Y; Shao C; Gong Y
    J Cell Sci; 2014 Nov; 127(Pt 21):4679-91. PubMed ID: 25189618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRL4B
    Chen Z; Wang K; Hou C; Jiang K; Chen B; Chen J; Lao L; Qian L; Zhong G; Liu Z; Zhang C; Shen H
    Sci Rep; 2017 Apr; 7(1):1175. PubMed ID: 28446751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.
    Huang W; Zhang J; Huo M; Gao J; Yang T; Yin X; Wang P; Leng S; Feng D; Chen Y; Yang Y; Wang Y
    Adv Sci (Weinh); 2021 May; 8(10):2001515. PubMed ID: 34026424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing.
    Yang Y; Liu R; Qiu R; Zheng Y; Huang W; Hu H; Ji Q; He H; Shang Y; Gong Y; Wang Y
    Oncogene; 2015 Jan; 34(1):104-18. PubMed ID: 24292684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUL4B renders breast cancer cells tamoxifen-resistant via miR-32-5p/ER-α36 axis.
    Wang Y; Pan X; Li Y; Wang R; Yang Y; Jiang B; Sun G; Shao C; Wang M; Gong Y
    J Pathol; 2021 Jun; 254(2):185-198. PubMed ID: 33638154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [CRL4B complex promotes the development of pancreatic cancer by inhibiting secreted frizzled related protein 1].
    Chen Y; Leng S; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):646-656. PubMed ID: 34289556
    [No Abstract]   [Full Text] [Related]  

  • 7. LSD1 coordinates with the SIN3A/HDAC complex and maintains sensitivity to chemotherapy in breast cancer.
    Yang Y; Huang W; Qiu R; Liu R; Zeng Y; Gao J; Zheng Y; Hou Y; Wang S; Yu W; Leng S; Feng D; Wang Y
    J Mol Cell Biol; 2018 Aug; 10(4):285-301. PubMed ID: 29741645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
    Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
    J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of TNF-α/NF-κB axis enhances CRL4B
    Zhang C; Chen B; Jiang K; Lao L; Shen H; Chen Z
    Mol Oncol; 2018 Apr; 12(4):476-494. PubMed ID: 29377600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis.
    Hu H; Yang Y; Ji Q; Zhao W; Jiang B; Liu R; Yuan J; Liu Q; Li X; Zou Y; Shao C; Shang Y; Wang Y; Gong Y
    Cancer Cell; 2012 Dec; 22(6):781-95. PubMed ID: 23238014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
    Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
    Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription.
    Zhang Y; Akinmade D; Hamburger AW
    Nucleic Acids Res; 2005; 33(18):6024-33. PubMed ID: 16254079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression.
    Gong Q; Wang Y; Zhu K; Bai X; Feng T; Sun G; Wang M; Pan X; Qin C
    Biochem Biophys Res Commun; 2023 Oct; 676():58-65. PubMed ID: 37487438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of the miR-194-CUL4B negative feedback loop drives tumorigenesis in non-small-cell lung carcinoma.
    Mi J; Zou Y; Lin X; Lu J; Liu X; Zhao H; Ye X; Hu H; Jiang B; Han B; Shao C; Gong Y
    Mol Oncol; 2017 Mar; 11(3):305-319. PubMed ID: 28164432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylation of RB-responsive promoters: requisite for specific gene repression but dispensable for cell cycle inhibition.
    Siddiqui H; Solomon DA; Gunawardena RW; Wang Y; Knudsen ES
    Mol Cell Biol; 2003 Nov; 23(21):7719-31. PubMed ID: 14560017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The homeobox gene Mohawk represses transcription by recruiting the sin3A/HDAC co-repressor complex.
    Anderson DM; Beres BJ; Wilson-Rawls J; Rawls A
    Dev Dyn; 2009 Mar; 238(3):572-80. PubMed ID: 19235719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sin3a regulates epithelial progenitor cell fate during lung development.
    Yao C; Carraro G; Konda B; Guan X; Mizuno T; Chiba N; Kostelny M; Kurkciyan A; David G; McQualter JL; Stripp BR
    Development; 2017 Jul; 144(14):2618-2628. PubMed ID: 28619823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes.
    Barrett AK; Shingare MR; Rechtsteiner A; Rodriguez KM; Le QN; Wijeratne TU; Mitchell CE; Membreno MW; Rubin SM; Müller GA
    Nat Commun; 2024 May; 15(1):4450. PubMed ID: 38789411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CUL4B promotes proliferation and inhibits apoptosis of human osteosarcoma cells.
    Chen Z; Shen BL; Fu QG; Wang F; Tang YX; Hou CL; Chen L
    Oncol Rep; 2014 Nov; 32(5):2047-53. PubMed ID: 25189186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRL2(LRR-1) targets a CDK inhibitor for cell cycle control in C. elegans and actin-based motility regulation in human cells.
    Starostina NG; Simpliciano JM; McGuirk MA; Kipreos ET
    Dev Cell; 2010 Nov; 19(5):753-64. PubMed ID: 21074724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.